AWA
BSX icon

Acumen Wealth Advisors’s Boston Scientific BSX Stock Holding History

Acumen Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Buy
257
+31
+14% +$1.68K ﹤0.01% 317
2026
Q1 		$14.2K Buy
+226
New +$18.1K ﹤0.01% 258

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Acumen Wealth Advisors's BSX Position: Q2 2026 in Review

Acumen Wealth Advisors increased its Boston Scientific (BSX) stake by 14% in Q2 2026, buying an estimated $1.68K and bringing the position to 257 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Acumen Wealth Advisors first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $14.2K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Acumen Wealth Advisors held 257 shares of Boston Scientific worth $11K as of Q2 2026.
  • Acumen Wealth Advisors bought 31 Boston Scientific shares in Q2 2026, an estimated $1.68K.
  • Boston Scientific made up ﹤0.01% of Acumen Wealth Advisors's portfolio in Q2 2026, its #317 holding.
  • Acumen Wealth Advisors first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Acumen Wealth Advisors's Boston Scientific position peaked at $14.2K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Acumen Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.